Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial
Version 2 2024-06-05, 11:31Version 2 2024-06-05, 11:31
Version 1 2021-07-08, 08:30Version 1 2021-07-08, 08:30
journal contribution
posted on 2024-06-05, 11:31authored byJA Hartmann, SJ Schmidt, PD McGorry, M Berger, GE Berger, EYH Chen, L de Haan, IB Hickie, S Lavoie, C Markulev, N Mossaheb, DH Nieman, M Nordentoft, A Polari, A Riecher-Rössler, MR Schäfer, M Schlögelhofer, S Smesny, A Thompson, SK Verma, HP Yuen, Alison YungAlison Yung, GP Amminger, B Nelson
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial